BUZZ — Nvidia — backed Iambic Therapeutics jumps in debut after $150 million IPO
* Iambic Therapeutics shares jump 19% to $19.08 in Nasdaq debut after $150 million US IPO * Nvidia-backed drug developer's stock opened at $16.15 apiece vs $16 IPO price * San Diego, California-based IAM sold 9.38 mln shares within $15 to $17 apiece marketed range * Biotech remains a bright spot in choppy broader IPO market * "For now, this looks more like a speed bump than a three-car pileup.. we've seen pullbacks like this before" - Matt Kennedy, senior strategist at Renaissance Capital * Iambic is advancing a pipeline of drug candidates developed using its AI platform to treat solid tumors (Reporting by Arasu Kannagi Basil in Bengaluru) ((mailto:ArasuKannagi.Basil@thomsonreuters.com;)